Tag: GCP compliance

Linking Equity in Recruitment to Benefit Sharing and Post-Trial Access

November 14, 2025November 14, 2025 digi

Linking Equity in Recruitment to Benefit Sharing and Post-Trial Access Linking Equity in Recruitment to Benefit Sharing and Post-Trial Access The landscape of clinical research is constantly evolving, necessitating rigorous ethical considerations in recruitment practices, especially concerning equity and fair access to trial benefits. This tutorial provides a comprehensive guide to integrating equity into recruitment…

Equity in Recruitment & Fair Participant Selection

Case Studies: Successes and Failures in Diverse Participant Enrollment

November 14, 2025November 14, 2025 digi

Case Studies: Successes and Failures in Diverse Participant Enrollment Case Studies: Successes and Failures in Diverse Participant Enrollment Understanding the Importance of Diverse Participant Enrollment in Clinical Trials Diverse participant enrollment in clinical trials is crucial for ensuring that the findings are applicable to a broad population. The inclusion of varied demographics—such as age, ethnicity,…

Equity in Recruitment & Fair Participant Selection

Using Real-World Data to Inform Equitable Recruitment Targets

November 14, 2025November 14, 2025 digi

Using Real-World Data to Inform Equitable Recruitment Targets Using Real-World Data to Inform Equitable Recruitment Targets In the evolving landscape of clinical research, the use of real-world data (RWD) has become a pivotal aspect in ensuring equitable recruitment targets across diverse populations. This tutorial will provide a comprehensive step-by-step guide tailored for clinical operations, regulatory…

Equity in Recruitment & Fair Participant Selection

Communications That Support Trust in Historically Underserved Communities

November 14, 2025November 14, 2025 digi

Communications That Support Trust in Historically Underserved Communities Despite advancements in science and medicine, historically underserved communities remain underrepresented in clinical trials. This article provides a step-by-step guide on enhancing equity in recruitment and ensuring fair participant selection in clinical trials, particularly in the context of the lecanemab clinical trial. The guidance provided herein is…

Equity in Recruitment & Fair Participant Selection

Sponsor and CRO Governance for Equity in Recruitment Across Portfolios

November 14, 2025November 14, 2025 digi

Sponsor and CRO Governance for Equity in Recruitment Across Portfolios Sponsor and CRO Governance for Equity in Recruitment Across Portfolios The governance of clinical trial operations by sponsors and Contract Research Organizations (CROs) plays a critical role in ensuring equity in participant recruitment, especially across diverse portfolios of studies. This article will provide a step-by-step…

Equity in Recruitment & Fair Participant Selection

Compensation Approaches for Vulnerable and Economically Disadvantaged Populations

November 14, 2025November 14, 2025 digi

Compensation Approaches for Vulnerable and Economically Disadvantaged Populations Clinical trials are an essential aspect of medical research, and ensuring access to these trials for vulnerable and economically disadvantaged populations is of paramount importance. This comprehensive guide details compensation approaches tailored for such groups, highlighting best practices, ethical considerations, and compliance with regulatory requirements in the…

Compensation, Reimbursement & Undue Influence

IRB/IEC Review of Payment Plans and Advertising Language

November 14, 2025November 14, 2025 digi

IRB/IEC Review of Payment Plans and Advertising Language IRB/IEC Review of Payment Plans and Advertising Language Introduction to IRB/IEC Review Process The review process conducted by Institutional Review Boards (IRBs) in the US and Independent Ethics Committees (IECs) in the EU and UK is critical to ensuring the ethical conduct of clinical trials. This process…

Compensation, Reimbursement & Undue Influence

Assessing Undue Influence When Setting Payment Levels and Schedules

November 14, 2025November 14, 2025 digi

Assessing Undue Influence When Setting Payment Levels and Schedules In the ever-evolving landscape of clinical trials, understanding the nuances of compensation structures is critical for clinical research organizations (CROs) and associated professionals. This comprehensive guide aims to address the ethical considerations surrounding undue influence in the context of payment levels and schedules in clinical studies….

Compensation, Reimbursement & Undue Influence

Distinguishing Compensation, Reimbursement and Incentives in Study Budgets

November 14, 2025November 14, 2025 digi

Distinguishing Compensation, Reimbursement and Incentives in Study Budgets Distinguishing Compensation, Reimbursement and Incentives in Study Budgets In the realm of clinical trials, understanding the nuances between compensation, reimbursement, and incentives is crucial for ensuring ethical compliance and maintaining regulatory integrity. This detailed guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals in…

Compensation, Reimbursement & Undue Influence

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws

November 14, 2025November 14, 2025 digi

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Clinical trials are fundamental to advancing medical knowledge, validating new therapies, and ensuring safety and efficacy. An important aspect of clinical trials is the ethical and regulatory handling of participant compensation. This guide provides a…

Compensation, Reimbursement & Undue Influence